Mark Pelka, MD
Interventional Cardiology · Naperville, ILNPI 1114389418
Payments from drug & device makers
Across 115 payments — averaging $76.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Edwards Lifesciences$956
- Abiomed$375
- Abbott$330
- Inari Medical, Inc.$129
- W. L. Gore & Associates, Inc.$111
- plus $783 from 18 others
What the payments were for
- Grants$4,00045%
- Travel & lodging$96911%
- Food & beverage$3,55340%
- Education$3134%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 27 | $6,148 |
| Edwards Lifesciences | 25 | $956 |
| Abiomed | 8 | $375 |
| Abbott | 17 | $330 |
| Inari Medical, Inc. | 6 | $129 |
| W. L. Gore & Associates, Inc. | 2 | $111 |
| Johnson & Johnson | 1 | $107 |
| Cardiovascular Systems Inc. | 2 | $91 |
| Boehringer Ingelheim | 3 | $86 |
| Novartis | 3 | $67 |
| Terumo Medical Corporation | 2 | $61 |
| Biosense Webster, Inc. | 2 | $47 |
| Actelion Pharmaceuticals US, Inc. | 1 | $42 |
| Cardiva Medical, Inc. | 2 | $40 |
| Surmodics, Inc. | 3 | $38 |
| Heartflow, Inc. | 2 | $38 |
| Penumbra, Inc. | 1 | $32 |
| Pfizer | 1 | $27 |
| Getinge USA Sales, LLC | 2 | $27 |
| Shockwave Medical, Inc | 1 | $22 |
| Merck | 1 | $19 |
| Livanova USA, Inc. | 1 | $14 |
| Amgen | 1 | $14 |
| Biotronik Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$1,294
- SAPIEN 3 Ultra RESILIA$251
- RESOLUTE ONYX$214
- EVOQUE$154
- SYMPLICITY G3$131
- PASCAL$123
- Impella$112
- XARELTO$107
How this compares
$8,834 in reported general payments places this provider in the 50th percentile of 303 interventional cardiology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 188 | $2,228 |
| Atorvastatin Calcium | 28 | $436 |
| Metoprolol Succinate | 24 | $200 |
| Rosuvastatin Calcium | 16 | $168 |
| Amiodarone Hcl | 11 | $94 |
| Furosemide | 19 | $54 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Naperville
- Mark GoodwinNaperville$282K
- Charles DavidsonChicago$5.8M
- Ravi RamanaPalos Park$2.8M
- Mark RicciardiEvanston$2.2M
- Andrei PopElk Grove Village$1.9M
- Krishna Rocha SinghSpringfield$1.7M
- Bruce LewisMaywood$1.3M
- Justin LevisayEvanston$837K
- Atman ShahChicago$794K
- Laura DavidsonChicago$661K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.